Loading stock data…
PAHC
$54.89+1.71 (+3.22%)
Market ClosedLast close May 1
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Phibro Animal Health Corporation in the Healthcare sector is trading at $54.89. The stock is currently near its 52-week high of $60.08, remaining 29.3% above its 200-day moving average. Technical signals show neutral RSI of 38 and bearish MACD signal, explaining why PAHC maintains its current momentum and trend strength. The Whystock Score of 85/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 38) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$54.89
Potential Downside
13.6%
Whystock Fair Value$47.42
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mine...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.22B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
24.20
Beta
Defensive asset. Lower volatility than the S&P 500.
0.69
Div Yield
Strong income play. Yield provides a meaningful total return floor.
88.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
14.52%
Volume
Today's trading volume
324,912
Recent News
PAHC vs. PODD: Which Stock Is the Better Value Option?
PAHC vs. PODD: Which Stock Is the Better Value Option?
Scoop Up These 4 GARP Stocks to Receive Handsome Returns
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. NVDA, PAHC, FTI and BURL are some such stocks.
Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million
This animal health and nutrition provider reported a notable insider sale amid a year of exceptional share price gains.
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway
Medical Products stocks face tariff and cost pressures, but Phibro Animal Health and peers leverage innovation, AI and demand trends to drive growth.
Assessing Phibro Animal Health (PAHC) Valuation After Powerful Share Price Momentum
Valuation snapshot and recent share performance Phibro Animal Health (PAHC) has drawn investor attention after recent share price moves, supported by positive annual revenue and net income growth, along with solid gains over the past month and the past three months. See our latest analysis for Phibro Animal Health. The recent 1 month share price return of 4.19% builds on a strong 90 day share price return of 42.05%, while the 1 year total shareholder return of 208.67% points to powerful...